OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium
OPKO Health (NASDAQ:OPK) announced its participation in the upcoming 3rd Annual Piper Sandler Virtual Obesity Symposium on June 26, 2025. The company's management will engage in a fireside discussion moderated by Edward Tentoff, Managing Director and Senior Biotechnology Analyst at Piper Sandler. Interested investors can register for the virtual event through their Piper Sandler representatives.
OPKO Health (NASDAQ:OPK) ha annunciato la sua partecipazione al 3° Simposio Virtuale Annuale sull'Obesità di Piper Sandler che si terrà il 26 giugno 2025. Il management dell'azienda parteciperà a una discussione informale moderata da Edward Tentoff, Managing Director e Senior Biotechnology Analyst presso Piper Sandler. Gli investitori interessati possono iscriversi all'evento virtuale tramite i loro rappresentanti Piper Sandler.
OPKO Health (NASDAQ:OPK) anunció su participación en el 3er Simposio Virtual Anual sobre Obesidad de Piper Sandler que se celebrará el 26 de junio de 2025. La dirección de la empresa participará en una charla informal moderada por Edward Tentoff, Director General y Analista Senior de Biotecnología en Piper Sandler. Los inversores interesados pueden registrarse para el evento virtual a través de sus representantes de Piper Sandler.
OPKO Health (NASDAQ:OPK)는 2025년 6월 26일에 열리는 제3회 연례 Piper Sandler 가상 비만 심포지엄에 참여한다고 발표했습니다. 회사 경영진은 Piper Sandler의 전무이사이자 수석 생명공학 분석가인 Edward Tentoff가 진행하는 화기애애한 토론에 참여할 예정입니다. 관심 있는 투자자들은 Piper Sandler 담당자를 통해 가상 행사에 등록할 수 있습니다.
OPKO Health (NASDAQ:OPK) a annoncé sa participation au 3e Symposium Virtuel Annuel sur l'Obésité de Piper Sandler qui se tiendra le 26 juin 2025. La direction de l'entreprise participera à une discussion informelle animée par Edward Tentoff, Managing Director et Analyste Senior en Biotechnologie chez Piper Sandler. Les investisseurs intéressés peuvent s'inscrire à l'événement virtuel via leurs représentants Piper Sandler.
OPKO Health (NASDAQ:OPK) gab bekannt, dass es am 3. jährlichen virtuellen Piper Sandler Adipositas-Symposium am 26. Juni 2025 teilnehmen wird. Das Management des Unternehmens wird an einer informellen Gesprächsrunde teilnehmen, die von Edward Tentoff, Managing Director und Senior Biotechnology Analyst bei Piper Sandler, moderiert wird. Interessierte Investoren können sich über ihre Piper Sandler Ansprechpartner für die virtuelle Veranstaltung anmelden.
- None.
- None.
MIAMI, June 25, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) today announced its participation in the 3rd Annual Piper Sandler Obesity Symposium being held virtually on June 26, 2025. Management will be participating in a fireside discussion moderated by Edward Tentoff, Managing Director, Senior Biotechnology Analyst. Investors can register for the symposium by contacting their Piper Sandler representative.
About OPKO Health
OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.
Contacts:
Alliance Advisors IR
Yvonne Briggs, 310-691-7100
ybriggs@allianceadvisors.com
or
Bruce Voss, 310-691-7100
bvoss@allianceadvisors.com
FAQ
When is OPKO Health (OPK) participating in the Piper Sandler Obesity Symposium?
Who will moderate OPKO Health's fireside discussion at the Piper Sandler symposium?
How can investors attend OPKO Health's presentation at the Piper Sandler Obesity Symposium?
What type of presentation will OPKO Health deliver at the Piper Sandler event?
